ATC Group: A12AA04 Calcium carbonate

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A12AA04 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A12 Mineral supplements
3 A12A Calcium
4 A12AA Calcium
5 A12AA04 Calcium carbonate

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 3 g

Active ingredients in A12AA04

Active Ingredient Description
Calcium carbonate

Calcium carbonate releases, in a pH-dependent manner, calcium ions in the stomach. Calcium carbonate is widely used as antacid and extensively used as a dietary supplement.

Related product monographs

Title Information Source Document Type  
ADCAL Chewable Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CALCICHEW Chewable tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Ecuador (EC)

Estonia (EE)

Finland (FI)

Germany (DE)

Ireland (IE)

Israel (IL)

Italy (IT)

Lithuania (LT)

Malta (MT)

Netherlands (NL)

Poland (PL)

South Africa (ZA)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.